ADVERTISEMENT
Tumor Treating Fields Associated With Significant Survival Benefit in Newly Diagnosed Glioblastoma
Matthew Ballo, MD, West Cancer Center, Germantown, Tennessee, discusses results from a meta-analysis of comparative studies showing a significant survival benefit with tumor treating fields therapy added to standard radiochemotherapy for patients with newly diagnosed glioblastoma.
Dr Ballo presented these findings at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting.
Source:
Ballo MT, Conlon P, Lavy-Shahaf G, et al. Real-world experience with tumor treating fields (TTFields) in newly diagnosed glioblastoma: A survival meta-analysis with systematic review. Presented at the ASCO Annual Meeting; June 2-6, 2023; Chicago, Illinois. Abstract 2059
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Visit the OLN Excellence Forums
Advertisement
Advertisement
Advertisement